Abstract:Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease (PD), but the pathogenic mechanism underlying LRRK2 mutations remains unresolved. In this study, we investigate the consequence of inactivation of LRRK2 and its functional homolog LRRK1 in male and female mice up to 25 months of age using behavioral, neurochemical, neuropathological, and ultrastructural analyses. We report that LRRK1 and LRRK2 double knock-out (LRRK DKO) mice exhibit impaired motor coordination at 12 months of age before the onset of dopaminergic neuron loss in the substantia nigra (SNpc). Moreover, LRRK DKO mice develop age-dependent, progressive loss of dopaminergic terminals in the striatum. Evoked dopamine (DA) release measured by fast-scan cyclic voltammetry in the dorsal striatum is also reduced in the absence of LRRK. Furthermore, LRRK DKO mice at 20-25 months of age show substantial loss of dopaminergic neurons in the SNpc. The surviving SNpc neurons in LRRK DKO mice at 25 months of age accumulate large numbers of autophagic and autolysosomal vacuoles and are accompanied with microgliosis. Surprisingly, the cerebral cortex is unaffected, as shown by normal cortical volume and neuron number as well as unchanged number of apoptotic cells and microglia in LRRK DKO mice at 25 months. These findings show that loss of LRRK function causes impairments in motor coordination, degeneration of dopaminergic terminals, reduction of evoked DA release, and selective loss of dopaminergic neurons in the SNpc, indicating that LRRK DKO mice are unique models for better understanding dopaminergic neurodegeneration in PD.SIGNIFICANCE STATEMENT Our current study employs a genetic approach to uncover the normal function of the LRRK family in the brain during mouse life span. Our multidisciplinary analysis demonstrates a critical normal physiological role of LRRK in maintaining the integrity and function of dopaminergic terminals and neurons in the aging brain, and show that LRRK DKO mice recapitulate several key features of PD and provide unique mouse models for elucidating molecular mechanisms underlying dopaminergic neurodegeneration in PD.

Leucine-rich Repeat Kinase 2 (LRRK2) Interacts with Parkin, and Mutant LRRK2 Induces Neuronal Degeneration

LRRK2, a puzzling protein: Insights into Parkinson's disease pathogenesis

Leucine-Rich Repeat Kinases

Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant Α-Synuclein

Leucine-rich Repeat Kinase 2 Interacts with Parkin, DJ-1 and PINK-1 in a Drosophila Melanogaster Model of Parkinson's Disease

Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival

Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson's Disease

Cell-autonomous role of leucine-rich repeat kinase in the protection of dopaminergic neuron survival

Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson's Disease?

Lrrk2 interaction with alpha-synuclein in diffuse Lewy body disease.

LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice

How Parkinson's Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types

The Role of the LRRK2 Gene in Parkinsonism

Kinase Activity of Mutant LRRK2 Mediates Neuronal Toxicity

“LRRK2: Autophagy and Lysosomal Activity”

LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1.

Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications.

Advance of the Study on LRRK2 Gene in Parkinson's Disease

Phosphorylation-dependent 14-3-3 Binding to LRRK2 is Impaired by Common Mutations of Familial Parkinson's Disease.

Lrrk2 interaction with α-synuclein in diffuse Lewy body disease

Motor Impairments and Dopaminergic Defects Caused by Loss of Leucine-Rich Repeat Kinase Function in Mice